SNT 8.33% 3.9¢ syntara limited

options exercised, page-6

  1. MrQ
    5,148 Posts.
    lightbulb Created with Sketch. 272
    Doesn't really matter what the price is short term other than for topping up.

    As long as they have enough cash to get to FDA outcome and keep running their other programs then it comes down to the price if they succeed or fail on that approval first.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.